United States · FDA National Drug Code directory
Deflazacort Oral Suspension
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 27808-249_8c84b375-6c97-4a02-b6aa-723504b9ea81
- Product NDC
- 27808-249
- Form
- SUSPENSION
- Composition / generic term
- Deflazacort Oral
- Labeler
- Cranbury Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240501
- Source listing expiry
- 20271231
Source-listed ingredients
- DEFLAZACORT — 22.75 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 13 mL in 1 BOTTLE (27808-249-01) · 27808-249-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →